Literature DB >> 21598250

IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis.

Hyun-Ja Jeong1, Seung-Youp Shin, Hyun-A Oh, Min-Ho Kim, Joong-Saeng Cho, Hyung-Min Kim.   

Abstract

IL-32 is a described pro-inflammatory cytokine produced by T lymphocytes, natural killer cells, monocytes, and epithelial cells. However, the specific mechanism of IL-32 on allergic rhinitis (AR) has not been elucidated. Here, we report a significant increase of IL-32 protein and mRNA in the nasal mucosa of AR patients. In addition, in nasal mucosa tissue from AR patients, the level of IL-32 production correlated with inflammation, IL-1β, IL-18, and granulocyte-macrophage colony-stimulating factor (GM-CSF). In an AR animal model, IL-32 significantly increased IgE and inflammatory cytokine levels. IL-32 expression was induced by recombinant human GM-CSF via activation of caspase-1 in eosinophils. In addition, depletion of IL-32 prevents the production of inflammatory cytokines in eosinophils. In conclusion, IL-32 is an important cytokine involved in the inflammation of AR. The regulation of IL-32 expression may form the basis of a new strategy for the treatment of AR.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598250     DOI: 10.1002/path.2899

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.

Authors:  Jeong Su Park; Su Yun Choi; Jeong-Hyung Lee; Maria Lee; Eun Sook Nam; Ae Lee Jeong; Sunyi Lee; Sora Han; Myeong-Sok Lee; Jong-Seok Lim; Do Young Yoon; Yongil Kwon; Young Yang
Journal:  Cell Oncol (Dordr)       Date:  2013-10-10       Impact factor: 6.730

2.  An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.

Authors:  Sun-Young Nam; Hee-Yun Kim; Jin-Young Min; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

3.  IL-32 promotes angiogenesis.

Authors:  Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

4.  Circulating and inducible IL-32α in chronic hepatitis C virus infection.

Authors:  Mark Collister; Julia Rempel; Jiaqi Yang; Kelly Kaita; Zach Raizman; Yuwen Gong; Gerald Minuk
Journal:  Can Liver J       Date:  2019-02-25

Review 5.  Role of interleukin-32 in chronic rhinosinusitis.

Authors:  Anjeni Keswani; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-02

6.  Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis.

Authors:  Sun-Young Nam; Hyun-A Oh; Youngjin Choi; Kun-Young Park; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  J Med Food       Date:  2014-08-04       Impact factor: 2.786

7.  Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.

Authors:  A Okamura; K Harada; M Nio; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

8.  IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis.

Authors:  Young-Mee Moon; Bo-Young Yoon; Yang-Mi Her; Hye-Joa Oh; Jae-Seon Lee; Kyoung-Woon Kim; Seon-Yeong Lee; Yun-Ju Woo; Kyung-Su Park; Sung-Hwan Park; Ho-Youn Kim; Mi-La Cho
Journal:  Arthritis Res Ther       Date:  2012-11-13       Impact factor: 5.156

9.  Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro.

Authors:  Hyun-Ja Jeong; Sun-Young Nam; Hyun-A Oh; Na-Ra Han; Young-Sick Kim; Phil-Dong Moon; Seung-Youp Shin; Min-Ho Kim; Hyung-Min Kim
Journal:  Arthritis Res Ther       Date:  2012-11-28       Impact factor: 5.156

10.  High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.

Authors:  Eun-Ju Lee; Eun-Jin Lee; Yeon-Ho Chung; Da-Hyun Song; Seokchan Hong; Chang-Keun Lee; Bin Yoo; Tae-Hwan Kim; Ye-Soo Park; Soo-Hyun Kim; Eun-Ju Chang; Yong-Gil Kim
Journal:  Arthritis Res Ther       Date:  2015-12-04       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.